Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: Results of in vitro studies

Future Microbiology

Volumn 12, Issue 8, 2017, Pages 721-731

  Fraile, Benito ^a   Alcover, Javier ^b   Royuela, Mar ^a   Rodríguez, David ^b   Chaves, Concepción ^a   Palacios, Ricardo ^b   Piqué, Núria ^c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b SA Avenida Gregorio Peces Barba   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

hibiscus; intestinal epithelial cells; medical device; propolis; urinary tract infection; xyloglucan

Indexed keywords

GLUCAN; HIBISCUS SABDARIFFA EXTRACT; PROPOLIS; UNCLASSIFIED DRUG; URINARY TRACT ANTIINFECTIVE AGENT; XYLOGLUCAN; ANTIINFECTIVE AGENT; XYLAN;

ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; BACTERIUM ADHERENCE; BROTH DILUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; FIMBRIA; HIBISCUS SABDARIFFA; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; UROLOGICAL THERAPEUTIC DEVICE; UROPATHOGENIC ESCHERICHIA COLI; APITHERAPY; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; HIBISCUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PHYTOTHERAPY;

ANTI-BACTERIAL AGENTS; APITHERAPY; BACTERIAL ADHESION; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; FIMBRIAE, BACTERIAL; GLUCANS; HIBISCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PROPOLIS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; XYLANS;

EID: 85022181576     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2017-0015     Document Type: Article

References (36)

1. García-Larrosa A, Alexe O. Efficacy and safety of a medical device versus placebo in the early treatment of patients with symptoms of urinary tract infection: a randomized controlled trial. Clin. Microbiol. 5, 1 (2016).
2. Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent. European J. Urol. 68, 452-458 (2015).
3. Behzadi P, Behzadi E. The microbial agents of urinary tract infections at Central Laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk. Klin. Tip. Bilim. 28, 445 (2008).
4. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl. 1A), S5-S13 (2002).
5. Lüthje P, Brauner A. Novel strategies in the prevention and treatment of urinary tract infections. Pathogens 5(1), pii: E13 (2016) (Epub ahead of print).
6. Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 4(5), 257-271 (2002).
7. Beerepoot M, Geerlings S. Non-antibiotic prophylaxis for urinary tract infections. Pathogens 5(2), pii: E36 (2016) (Epub ahead of print).
8. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340, c2096 (2010).
9. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. www.who.int/drugresistance/
10. de Servi B, Ranzini F, Piqué N. Effect of Utipro(®) (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study. Future Microbiol. 11, 651-658 (2016).
11. Howell AB. Cranberry proanthocyanidins and the maintenance of urinary tract health. Crit. Rev. Food Sci. Nutr. 42(Suppl. 3), 273-278 (2002).
12. Howell AB, Botto H, Combescure C et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect. Dis. 10, 94 (2010).
13. Gupta A, Dwivedi M, Mahdi AA, Nagana Gowda GA, Khetrapal CL, Bhandari M. Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol. Res. 40(2), 143-150 (2012).
14. Chisholm AH. Probiotics in preventing recurrent urinary tract infections in women: a literature review. Urol. Nurs. 35(1), 18-21 (2015).
15. Salvatorelli N, García-Larrosa A, Allegrini A, Pavone D. A new approach to the treatment of uncomplicated cystitis: results of a randomized placebo-controlled clinical trial. Urol. Int. 97(3), 347-351 (2016).
16. Lavigne JP, Vitrac X, Bernard L, Bruyère F, Sotto A. Propolis can potentialise the anti-adhesion activity of proanthocyanidins on uropathogenic Escherichia coli in the prevention of recurrent urinary tract infections. BMC Res. Notes 4, 522 (2011).
17. Alshami I, Alharbi AE. Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections. Asian Pac. J. Trop. Biomed. 4(2), 104-108 (2014).
18. Gnessi L, Bacarea V, Marusteri M, Piqué N. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 15(1), 153 (2015).
19. Ple?ea Condratovici C, Bacarea V, Piqué N. Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, clinical trial. Gastroenterol. Res. Pract. 2016, 6874207 (2016).
20. Bueno L, Theodorou V, Sekkal S. Xyloglucan: a new agent to protect the intestinal mucosa and to prevent bacterially-mediated alteration of tight junction permeability. United European Gastroenterol. J. 2(Suppl. 1), A591 Abstract P1675 (2014).
21. Katouli M. Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iran. J. Microbiol. 2(2), 59-72 (2010).
22. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8(3), 207-217 (2010).
23. Frömmel U, Lehmann W, Rödiger S et al. Adhesion of human and animal Escherichia coli strains in association with their virulenceassociated genes and phylogenetic origins. Appl. Environ. Microbiol. 79(19), 5814-5829 (2013).
24. Afshar K, Stothers L, Scott H, MacNeily AE. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J. Urol. 188(Suppl. 4), 1584-1587 (2012).
25. Vasileiou I, Katsargyris A, Theocharis S, Giaginis C. Current clinical status on the preventive effects of cranberry consumption against urinary tract infections. Nutr. Res. 33, 595-607 (2013).
26. Melican K, Sandoval RM, Kader A et al. Uropathogenic Escherichia coli P and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 7(2), e1001298 (2011).
27. Godaly G, Svanborg C. Urinary tract infections revisited. Kidney Int. 71, 721-723 (2007).
28. Wright KJ, Hultgren SJ. Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract. Future Microbiol. 1, 75-87 (2006).
29. Waksman G1, Hultgren SJ. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat. Rev. Microbiol. 7, 765-774 (2009).
30. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18(6), 1215-1223 (1997).
31. Webber MM, Bello D, Kleinman HK, Hoffman MP. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18(6), 1225-1231 (1997).
32. Okamoto M, Webber MM, Quader S, Oyasu R. Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea. Prostate 35(4), 255-262 (1998).
33. Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol. Appl. Pharmacol. 164(3), 291-300 (2000).
34. Quader ST, Bello-DeOcampo D, Williams DE, Kleinman HK, Webber MM. Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model. Mutat. Res. 496(1-2), 153-161 (2001).
35. Fasugba O, Koerner J, Mitchell BG, Gardner A. Systematic review and meta-analysis of the effectiveness of antiseptic agents for meatal cleaning in the prevention of catheterassociated urinary tract infections. J. Hosp. Infect. 95, 233-242 (2017).
36. Chenoweth C, Saint S. Preventing catheterassociated urinary tract infections in the intensive care unit. Crit. Care Clin. 29, 19-32 (2013).